Cargando…
Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow
OBJECTIVE: Recent studies have demonstrated that miRNA-155 is involved in the occurrence and development of atherosclerosis. Furthermore, miRNA-155 has emerged as a new indirect marker for inflammation associated with adverse outcomes in oncology and cardiovascular diseases. This study investigated...
Autores principales: | Su, Qiang, Yang, Huafeng, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036848/ https://www.ncbi.nlm.nih.gov/pubmed/30046360 http://dx.doi.org/10.1155/2018/6345284 |
Ejemplares similares
-
miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
por: Chen, Tong, et al.
Publicado: (2020) -
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
por: Ratnasari, Neneng, et al.
Publicado: (2022) -
Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020) -
Exosomal miRNA-155 and miRNA-146a are promising prognostic biomarkers of the severity of hemorrhagic fever with renal syndrome
por: Gilyazova, Irina, et al.
Publicado: (2022) -
Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)